Cite

HARVARD Citation

    Peng, L. et al. (2020). A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib. Expert opinion on drug safety. 19 (11), pp. 1505-1511. [Online]. 
  
Back to record